{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:45:10Z","timestamp":1793285110496,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["5R37MH060009"],"award-info":[{"award-number":["5R37MH060009"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007049","name":"Evelyn F. McKnight Brain Research Foundation","doi-asserted-by":"publisher","award":["1U19AG073172-01"],"award-info":[{"award-number":["1U19AG073172-01"]}],"id":[{"id":"10.13039\/100007049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062547-01"],"award-info":[{"award-number":["R01AG062547-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["5P01AG15379"],"award-info":[{"award-number":["5P01AG15379"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["2R01AG014713"],"award-info":[{"award-number":["2R01AG014713"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1RF1AG048080-01"],"award-info":[{"award-number":["1RF1AG048080-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R01AG082093-01"],"award-info":[{"award-number":["1R01AG082093-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG063913"],"award-info":[{"award-number":["RF1AG063913"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012513","name":"Coins for Alzheimer's Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007457","name":"JPB Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neuron.2024.10.029","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T10:35:44Z","timestamp":1732703744000},"page":"205-224.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"113","author":[{"given":"Pourya","family":"Naderi Yeganeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Su","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Jorfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katju\u0161a","family":"Koler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thejesh","family":"Kalatturu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djuna","family":"von Maydell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younjung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Abarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grisilda","family":"Bakiasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Cetinbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Sadreyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Griciuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Quinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolph E.","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Hide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2024.10.029_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neuron.2024.10.029_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuron.2024.10.029_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuron.2024.10.029_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuron.2024.10.029_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042915-103753","article-title":"Update on Alzheimer\u2019s disease therapy and prevention strategies","volume":"68","author":"Graham","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuron.2024.10.029_bib6","article-title":"Alzheimer\u2019s disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimers. Dement. (N Y)"},{"key":"10.1016\/j.neuron.2024.10.029_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer\u2019s disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2024.10.029_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15120-3","article-title":"Amyloid-\u03b242\/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer\u2019s disease","volume":"11","author":"Kwak","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2024.10.029_bib9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nprot.2015.065","article-title":"A 3D human neural cell culture system for modeling Alzheimer\u2019s disease","volume":"10","author":"Kim","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuron.2024.10.029_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","article-title":"A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease","volume":"21","author":"Park","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900962","article-title":"Blood-brain barrier dysfunction in a 3D in\u00a0vitro model of Alzheimer\u2019s disease","volume":"6","author":"Shin","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.neuron.2024.10.029_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","article-title":"Infiltrating CD8+ T\u00a0cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model","volume":"26","author":"Jorfi","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/bies.201500063","article-title":"Alzheimer\u2019s in 3D culture: challenges and perspectives","volume":"37","author":"D\u2019Avanzo","year":"2015","journal-title":"BioEssays"},{"key":"10.1016\/j.neuron.2024.10.029_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13024-016-0139-7","article-title":"3D culture models of Alzheimer\u2019s disease: a road map to a \u201ccure-in-a-dish.\u201d","volume":"11","author":"Choi","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2024.10.029_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4103\/1673-5374.266046","article-title":"Can mouse models mimic sporadic Alzheimer\u2019s disease?","volume":"15","author":"Foidl","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuron.2024.10.029_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","article-title":"Modeling Alzheimer\u2019s disease with iPSC-derived brain cells","volume":"25","author":"Penney","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2024.10.029_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40035-019-0161-0","article-title":"Alzheimer\u2019s in a dish - induced pluripotent stem cell-based disease modeling","volume":"8","author":"de Leeuw","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuron.2024.10.029_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-017-0268-4","article-title":"Stem cell models of Alzheimer\u2019s disease: progress and challenges","volume":"9","author":"Arber","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuron.2024.10.029_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.89","article-title":"Human whole genome genotype and transcriptome data for Alzheimer\u2019s and other neurodegenerative diseases","volume":"3","author":"Allen","year":"2016","journal-title":"Sci. Data"},{"key":"10.1016\/j.neuron.2024.10.029_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.185","article-title":"The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer\u2019s disease","volume":"5","author":"Wang","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.neuron.2024.10.029_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107908","article-title":"Meta-analysis of the Alzheimer\u2019s disease human brain transcriptome and functional dissection in mouse models","volume":"32","author":"Wan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2024.10.029_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5398","article-title":"Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets","volume":"7","author":"Neff","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuron.2024.10.029_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002707","article-title":"Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants","volume":"8","author":"Zou","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuron.2024.10.029_bib24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","article-title":"A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease","volume":"21","author":"Mostafavi","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002375","article-title":"Ten years of pathway analysis: current approaches and outstanding challenges","volume":"8","author":"Khatri","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neuron.2024.10.029_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20177998","article-title":"The relative resistance of children to sepsis mortality: from pathways to drug candidates","volume":"14","author":"Joachim","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.neuron.2024.10.029_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/gm472","article-title":"Pathprinting: An integrative approach to understand the functional basis of disease","volume":"5","author":"Altschuler","year":"2013","journal-title":"Genome Med."},{"key":"10.1016\/j.neuron.2024.10.029_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006042","article-title":"The Pathway Coexpression Network: Revealing pathway relationships","volume":"14","author":"Pita-Ju\u00e1rez","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neuron.2024.10.029_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad418","article-title":"PanomiR: a systems biology framework for analysis of multi-pathway targeting by miRNAs","volume":"24","author":"Naderi Yeganeh","year":"2023","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.neuron.2024.10.029_bib30","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuron.2024.10.029_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1523\/JNEUROSCI.23-02-00493.2003","article-title":"Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy","volume":"23","author":"Grace","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbadis.2006.11.007","article-title":"Focal adhesions regulate Abeta signaling and cell death in Alzheimer\u2019s disease","volume":"1772","author":"Caltagarone","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuron.2024.10.029_bib33","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3389\/fimmu.2017.01805","article-title":"Nuclear factor-kappa B and Alzheimer disease, unifying genetic and environmental risk factors from cell to humans","volume":"8","author":"Jones","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuron.2024.10.029_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1871527316666170807130011","article-title":"NF-\u03baB as a key mediator of brain inflammation in Alzheimer\u2019s disease","volume":"18","author":"Ju Hwang","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuron.2024.10.029_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","article-title":"Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease","volume":"595","author":"McAlpine","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2024.10.029_bib36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3233\/JAD-160702","article-title":"Mitochondrial dysfunction and synaptic transmission failure in Alzheimer\u2019s disease","volume":"57","author":"Guo","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2024.10.029_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.142","article-title":"A multi-omic atlas of the human frontal cortex for aging and Alzheimer\u2019s disease research","volume":"5","author":"De Jager","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.neuron.2024.10.029_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2019.07.010","article-title":"A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP \u03b2-CTFs, not A\u03b2","volume":"104","author":"Kwart","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2024.10.029_bib39","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/728571","article-title":"Calpain dysregulation in Alzheimer\u2019s disease","volume":"2012","author":"Ferreira","year":"2012","journal-title":"ISRN Biochem."},{"key":"10.1016\/j.neuron.2024.10.029_bib40","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/med.21534","article-title":"Involvement of calpain in the neuropathogenesis of Alzheimer\u2019s disease","volume":"39","author":"Mahaman","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuron.2024.10.029_bib41","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3233\/JAD-215182","article-title":"Calpain-mediated alterations in astrocytes before and during amyloid chaos in Alzheimer\u2019s disease","volume":"84","author":"Schultz","year":"2021","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2024.10.029_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jnc.14475","article-title":"Calcineurin: directing the damage in Alzheimer disease: An Editorial for \u201cNeuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain\u201d on page 24","volume":"147","author":"Norris","year":"2018","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuron.2024.10.029_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnagi.2018.00199","article-title":"Ca2+, astrocyte activation and calcineurin\/NFAT signaling in age-related neurodegenerative diseases","volume":"10","author":"Sompol","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.710683","article-title":"The Unifying Hypothesis of Alzheimer\u2019s disease: Heparan sulfate proteoglycans\/glycosaminoglycans\u00a0are key as first hypothesized over 30 years ago","volume":"13","author":"Snow","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1474-4422(03)00484-8","article-title":"Heparan sulphate proteoglycans in Alzheimer\u2019s disease and amyloid-related disorders","volume":"2","author":"van Horssen","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuron.2024.10.029_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnagi.2017.00007","article-title":"Protein tyrosine phosphatase 1B (PTP1B): a Potential Target for Alzheimer\u2019s Therapy?","volume":"9","author":"Vieira","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib47","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.18632\/aging.204045","article-title":"YAP: a novel target for Alzheimer\u2019s disease","volume":"14","author":"Xu","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.neuron.2024.10.029_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13465","article-title":"YAP prevents premature senescence of astrocytes and cognitive decline of Alzheimer\u2019s disease through regulating CDK6 signaling","volume":"20","author":"Xu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuron.2024.10.029_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.635636","article-title":"The p38MAPK-MK2 signaling axis as a critical link between inflammation and synaptic transmission","volume":"9","author":"Beamer","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuron.2024.10.029_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13195-021-00843-2","article-title":"A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer\u2019s disease","volume":"13","author":"Prins","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuron.2024.10.029_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/jnc.14687","article-title":"Nuclear factor-kappa \u03b2 as a therapeutic target for Alzheimer\u2019s disease","volume":"150","author":"Jha","year":"2019","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuron.2024.10.029_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/156720509787313970","article-title":"DNA damage and repair in Alzheimer\u2019s disease","volume":"6","author":"Copped\u00e8","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuron.2024.10.029_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2019.00324","article-title":"Perturbations of ubiquitin-proteasome-mediated proteolysis in aging and Alzheimer\u2019s disease","volume":"11","author":"Hegde","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-180874","article-title":"Aberrant neuronal cell cycle re-entry: The pathological confluence of Alzheimer\u2019s disease and brain insulin resistance, and its relation to cancer","volume":"67","author":"Koseoglu","year":"2019","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2024.10.029_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/srep31158","article-title":"A\u03b2 induces excitotoxicity mediated by APC\/C-Cdh1 depletion that can be prevented by glutaminase inhibition promoting neuronal survival","volume":"6","author":"Fuchsberger","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2024.10.029_bib56","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/emboj.2008.195","article-title":"Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity","volume":"27","author":"Maestre","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.neuron.2024.10.029_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1086540","article-title":"APC\/C-Cdh1-targeted substrates as potential therapies for Alzheimer\u2019s disease","volume":"13","author":"Lapresa","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuron.2024.10.029_bib58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2024.10.029_bib59","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1523\/JNEUROSCI.23-17-06740.2003","article-title":"\u0392-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex","volume":"23","author":"Dougherty","year":"2003","journal-title":"J.\u00a0Neurosci."},{"issue":"suppl 2","key":"10.1016\/j.neuron.2024.10.029_bib60","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.3233\/JAD-2012-111664","article-title":"Calcium channel blockers and Alzheimer\u2019s disease: potential relevance in treatment strategies of metabolic syndrome","volume":"30","author":"Goodison","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2024.10.029_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuron.2024.10.029_bib62","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41380-018-0221-3","article-title":"Endosomal sorting and trafficking, the retromer complex and neurodegeneration","volume":"24","author":"Vagnozzi","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2024.10.029_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-019-0323-7","article-title":"Endo-lysosomal dysregulations and late-onset Alzheimer\u2019s disease: impact of genetic risk factors","volume":"14","author":"Van Acker","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2024.10.029_bib64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1242\/dmm.028613","article-title":"RNA metabolism in neurodegenerative disease","volume":"10","author":"Liu","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neuron.2024.10.029_bib65","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4172\/2168-975X.1000232","article-title":"DNA-PK and P38 MAPK: A kinase collusion in Alzheimer\u2019s disease?","volume":"6","author":"Kanungo","year":"2017","journal-title":"Brain Disord. Ther."},{"key":"10.1016\/j.neuron.2024.10.029_bib66","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/molecules22081287","article-title":"Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Lee","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.neuron.2024.10.029_bib67","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.3390\/ijms21165624","article-title":"Involvement of p38 MAPK in synaptic function and dysfunction","volume":"21","author":"Falcicchia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuron.2024.10.029_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-016-0221-y","article-title":"Selective suppression of the \u03b1 isoform of p38 MAPK rescues late-stage tau pathology","volume":"8","author":"Maphis","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuron.2024.10.029_bib69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcp.22038","article-title":"Cdc20 proteolysis requires p38 MAPK signaling and Cdh1-independent APC\/C ubiquitination during spindle assembly checkpoint activation by cadmium","volume":"223","author":"Yen","year":"2010","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.neuron.2024.10.029_bib70","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jmcb\/mjw036","article-title":"Regulation of Hippo signalling by p38 signalling","volume":"8","author":"Huang","year":"2016","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.neuron.2024.10.029_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/revneuro-2018-0008","article-title":"Role of p38\/MAPKs in Alzheimer\u2019s disease: implications for amyloid beta toxicity targeted therapy","volume":"30","author":"Kheiri","year":"2018","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib72","doi-asserted-by":"crossref","first-page":"32553","DOI":"10.1074\/jbc.M803963200","article-title":"The p38 mitogen-activated protein kinase augments nucleotide excision repair by mediating DDB2 degradation and chromatin relaxation","volume":"283","author":"Zhao","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2024.10.029_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14728222.2021.1924151","article-title":"Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer\u2019s disease","volume":"25","author":"Srivastava","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuron.2024.10.029_bib74","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib75","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.bbr.2014.08.034","article-title":"Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice","volume":"274","author":"Kanno","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2024.10.029_bib76","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease","volume":"132","author":"Sadleir","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2024.10.029_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","article-title":"The Alzheimer\u2019s \u03b2-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques","volume":"126","author":"Kandalepas","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2024.10.029_bib78","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1074\/jbc.M115.695916","article-title":"Deficiency of neuronal p38\u03b1 MAPK attenuates amyloid pathology in Alzheimer disease mouse and cell models through facilitating lysosomal degradation of BACE1","volume":"291","author":"Schn\u00f6der","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2024.10.029_bib79","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s00018-009-0086-3","article-title":"Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology","volume":"66","author":"Kostenko","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuron.2024.10.029_bib80","doi-asserted-by":"crossref","first-page":"W304","DOI":"10.1093\/nar\/gkab359","article-title":"KEA3: improved kinase enrichment analysis via data integration","volume":"49","author":"Kuleshov","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuron.2024.10.029_bib81","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s43587-021-00071-1","article-title":"Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer\u2019s disease","volume":"1","author":"Morshed","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.neuron.2024.10.029_bib82","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40262-012-0025-6","article-title":"Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases","volume":"52","author":"Yang","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neuron.2024.10.029_bib83","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/j.1532-2149.2012.00256.x","article-title":"Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study","volume":"17","author":"Ostenfeld","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuron.2024.10.029_bib84","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0091270010397050","article-title":"An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease","volume":"52","author":"Lomas","year":"2012","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuron.2024.10.029_bib85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/jpet.117.240861","article-title":"Pharmacological and toxicological properties of the potent oral \u03b3-secretase modulator BPN-15606","volume":"362","author":"Wagner","year":"2017","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2024.10.029_bib86","doi-asserted-by":"crossref","first-page":"19472","DOI":"10.1074\/jbc.M414221200","article-title":"BIRB796 inhibits all p38 MAPK isoforms in\u00a0vitro and in\u00a0vivo","volume":"280","author":"Kuma","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2024.10.029_bib87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cgh.2005.11.013","article-title":"Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"4","author":"Schreiber","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuron.2024.10.029_bib88","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jat.1622","article-title":"A possible mechanism for hepatotoxicity induced by BIRB-796, an orally active p38 mitogen-activated protein kinase inhibitor","volume":"31","author":"Iwano","year":"2011","journal-title":"J.\u00a0Appl. Toxicol."},{"key":"10.1016\/j.neuron.2024.10.029_bib89","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.110.166173","article-title":"A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor \u03b1 production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation","volume":"333","author":"Mourey","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2024.10.029_bib90","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.20172063","article-title":"Selective inhibition of the p38\u03b1 MAPK\u2013MK2 axis inhibits inflammatory cues including inflammasome priming signals","volume":"215","author":"Wang","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuron.2024.10.029_bib91","first-page":"123","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the MK2 inhibitor ATI-450 in healthy subjects: A placebo-controlled, randomized phase 1 study","volume":"13","author":"Gordon","year":"2021","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.neuron.2024.10.029_bib92","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s43587-021-00077-9","article-title":"The phosphorylation cascade hypothesis of Alzheimer\u2019s disease","volume":"1","author":"Brinkmalm","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.neuron.2024.10.029_bib93","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.aah6205","article-title":"Site-specific phosphorylation of tau inhibits amyloid-\u03b2 toxicity in Alzheimer\u2019s mice","volume":"354","author":"Ittner","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neuron.2024.10.029_bib94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-020-02191-1","article-title":"Reduction of advanced tau-mediated memory deficits by the MAP kinase p38\u03b3","volume":"140","author":"Ittner","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2024.10.029_bib95","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2022.01.005","article-title":"High Level forebrain expression of active tau kinase p38\u03b3 exacerbates cognitive dysfunction in aged APP-transgenic Alzheimer\u2019s mice","volume":"484","author":"Asih","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2024.10.029_bib96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1742-2094-8-79","article-title":"Microglial p38\u03b1 MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (A\u03b2)","volume":"8","author":"Bachstetter","year":"2011","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuron.2024.10.029_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13717","article-title":"The MK2 cascade mediates transient alteration in mGluR-LTD and spatial learning in a murine model of Alzheimer\u2019s disease","volume":"21","author":"Privitera","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuron.2024.10.029_bib98","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","article-title":"Soluble A\u03b2 oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors","volume":"31","author":"Li","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib99","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.191.5.859","article-title":"Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells","volume":"191","author":"Allen","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuron.2024.10.029_bib100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/10061","article-title":"MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis","volume":"1","author":"Kotlyarov","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuron.2024.10.029_bib101","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuron.2024.10.029_bib102","doi-asserted-by":"crossref","first-page":"36646","DOI":"10.1074\/jbc.M112117200","article-title":"The presenilin 1 deltaE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations","volume":"277","author":"Cedazo-Minguez","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2024.10.029_bib103","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cell.2006.06.059","article-title":"Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer\u2019s disease-linked mutations","volume":"126","author":"Tu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2024.10.029_bib104","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ceca.2011.05.013","article-title":"Presenilins function in ER calcium leak and Alzheimer\u2019s disease pathogenesis","volume":"50","author":"Supnet","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuron.2024.10.029_bib105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/JMN:29:1:29","article-title":"Role of glutamine deamidation in neurodegenerative diseases associated with triplet repeat expansions: a hypothesis","volume":"29","author":"Hasan","year":"2006","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuron.2024.10.029_bib106","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0021-9258(18)48531-6","article-title":"Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau","volume":"267","author":"Greenberg","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2024.10.029_bib107","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuron.2024.10.029_bib108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuron.2024.10.029_bib109","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuron.2024.10.029_bib110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/biostatistics\/kxr054","article-title":"Removing technical variability in RNA-seq data using conditional quantile normalization","volume":"13","author":"Hansen","year":"2012","journal-title":"Biostatistics"},{"key":"10.1016\/j.neuron.2024.10.029_bib111","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuron.2024.10.029_bib112","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J.\u00a0R. Stat. Soc."},{"key":"10.1016\/j.neuron.2024.10.029_bib113","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuron.2024.10.029_bib114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuron.2024.10.029_bib115","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: Precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuron.2024.10.029_bib116","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ncb1602","article-title":"BACE1 regulates voltage-gated sodium channels and neuronal activity","volume":"9","author":"Kim","year":"2007","journal-title":"Nat. Cell Biol."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627324008006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627324008006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:34:50Z","timestamp":1778546090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627324008006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0896627324008006"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2024.10.029","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2024.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}